John Mendlein Fate Therapeutics Inc (FATE) insider trading activity

John Mendlein is of FATE THERAPEUTICS INC. Currently has a direct ownership of 311,231 shares of FATE, which is worth approximately $516,643. The most recent transaction as insider was on Jan 19, 2023, when has been sold 28,461 shares (Common Stock) at a price of $1.37 per share, resulting in proceeds of $38,991. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 311K

0% 3M change

0% 12M change

Total Value Held $516,643

JOHN MENDLEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 19 2023	BUY Exercise of conversion of derivative security	$38,991 $1.37 p/Share	28,461 Added 8.38%	311,231 Common Stock
Jan 13 2023	BUY Open market or private purchase	$198,906 $5.43 p/Share	36,631 Added 11.47%	282,770 Common Stock
Jan 11 2023	BUY Open market or private purchase	$499,232 $5.67 p/Share	88,048 Added 26.35%	246,139 Common Stock
Jun 09 2022	BUY Grant, award, or other acquisition	-	8,650 Added 4.93%	166,741 Common Stock
Jun 03 2022	SELL Open market or private sale	$31,086 $22.79 p/Share	1,364 Reduced 0.86%	158,091 Common Stock
Mar 10 2022	SELL Open market or private sale	$1,108,142 $35.11 p/Share	31,562 Reduced 16.52%	159,455 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	$51,446 $1.63 p/Share	31,562 Added 14.18%	191,017 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	2,681 Added 1.65%	159,455 Common Stock

Also insider at

OMGA

Omega Therapeutics, Inc. Healthcare

John Mendlein

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Value

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

Operation

Value

Type

News

Receive news related to FATE THERAPEUTICS INC

Track Activities on FATE

Account